Luminex assays from the in vitro studies revealed that iNKT cells exhibit Th17 (IL-17, IL-22), Th-2 (IL-4) and Th1 (IFN-γ, IL-18) response to R-P4 and HH GBS, as observed previously with other lipids [82,83]. The gene discussed is IL22; the disease is Guillain-Barre syndrome.